Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome.

Comparing Different Treatment in aHUS Patients, aHUS Family, and Healthy Controls In this subgroup analysis of aHUS treatment, intermediate monocyte enrichment showed an increasing trend from the plasma exchange group to the combined plasma exchange with anti-complement therapy group, aHUS family group, and healthy control group ( Figure 7 a).

also in 63,971 other papers